The FDA on May 10 authorized Pfizer’s COVID-19 vaccine to be used in children as young as 12. The drugmaker said it plans to submit an FDA approval application in September for the vaccine’s use in children ages 2 to 11.
However, just 30 percent of parents with children ages 12-15 said they would get their child vaccinated against COVID-19 as soon as they’re eligible, according to survey results released May 6 by Kaiser Family Foundation. Vaccine hesitancy was even more prevalent among parents with young children.
Many parents who are hesitant about getting their children vaccinated against COVID-19 ensure their children are up-to-date with their other vaccinations. They aren’t against vaccines, they’re concerned about the uncertainty of future outcomes that come along with such a novel vaccine.
Below are three key concerns parents have that marketers should know about:
- Some parents don’t want their children to resent them if their children end up experiencing a negative long-term outcome as a result of a COVID-19 vaccine.
- Some parents are concerned COVID-19 vaccine could affect their children’s puberty and fertility.
- Some parents (especially those with younger children) are waiting until more children are vaccinated because they are worried about which side effects and potential allergic reactions their children may face.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
